- Home
- EQS vs MYO Comparison
EQS vs MYO Comparison
Compare EQS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQS
- MYO
- Stock Information
- Founded
- EQS 1991
- MYO 2004
- Country
- EQS United States
- MYO United States
- Employees
- EQS N/A
- MYO N/A
- Industry
- EQS Finance Companies
- MYO Industrial Specialties
- Sector
- EQS Finance
- MYO Health Care
- Exchange
- EQS Nasdaq
- MYO Nasdaq
- Market Cap
- EQS 33.7M
- MYO 36.5M
- IPO Year
- EQS N/A
- MYO 2017
- Fundamental
- Price
- EQS $1.95
- MYO $0.83
- Analyst Decision
- EQS
- MYO Strong Buy
- Analyst Count
- EQS 0
- MYO 3
- Target Price
- EQS N/A
- MYO $7.83
- AVG Volume (30 Days)
- EQS 11.9K
- MYO 2.0M
- Earning Date
- EQS 01-01-0001
- MYO 11-10-2025
- Dividend Yield
- EQS N/A
- MYO N/A
- EPS Growth
- EQS N/A
- MYO N/A
- EPS
- EQS N/A
- MYO N/A
- Revenue
- EQS $1,355,000.00
- MYO $40,760,091.00
- Revenue This Year
- EQS N/A
- MYO $24.69
- Revenue Next Year
- EQS N/A
- MYO $20.91
- P/E Ratio
- EQS N/A
- MYO N/A
- Revenue Growth
- EQS 60.35
- MYO 93.08
- 52 Week Low
- EQS $0.74
- MYO $0.80
- 52 Week High
- EQS $2.49
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- EQS 47.70
- MYO 33.31
- Support Level
- EQS $1.75
- MYO $0.81
- Resistance Level
- EQS $2.01
- MYO $0.97
- Average True Range (ATR)
- EQS 0.09
- MYO 0.08
- MACD
- EQS 0.00
- MYO -0.03
- Stochastic Oscillator
- EQS 58.28
- MYO 3.30
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).